MD Health, the specialist healthcare communications agency known for blending creativity with scientific depth, today announces that it has won a significant brief with Mindpeak — a leading German innovator in AI-powered cancer diagnostics — via a competitive pitch process.
The win represents a significant step forward in the growth of MD Health, cementing the agency's role as a go-to partner for science-led, purpose-driven organisations transforming the future of health. It follows a series of high-impact briefs across pharma, diagnostics and health equity, and underscores MD Health's growing international footprint in Europe, the UK and the US.
Based in Hamburg, Germany, Mindpeak is transforming the pathology landscape by developing AI tools that support the fast, accurate and scalable diagnosis of a variety of prevalent cancers such as breast, prostate and lung. With regulatory clearances in Europe and the US, and growing adoption in clinical settings around the world, the company is now entering a new phase of international growth. MD Health has been appointed to support Mindpeak with a full strategic communications programme, encompassing brand positioning, media and stakeholder engagement and content development.
“Mindpeak represents everything we believe in — bold innovation with real-world impact,” said Mita Dhullipala, Founder and CEO of MD Health. “Mindpeak is not just innovating -- it is redefining how cancer is diagnosed and how technology can meaningfully support clinical decision-making. We're thrilled to be working alongside a team that shares our values around impact and ambition. Together, we'll build a communications platform that reflects the scientific rigour, vision and global potential of the Mindpeak brand.”
This client partnership underscores MD Health's growing reputation as the go-to agency for ambitious health tech and life sciences organisations looking to scale their influence, sharpen their narratives and reach the audiences that matter.
ABOUT MINDPEAK
Mindpeak is the leading company in AI-powered digital pathology, bridging the gap from biomarker development to clinical diagnostics. Founded in 2018, Mindpeak's AI technology enables laboratories to extract actionable insights from H&E, IHC and mIF tissue images — ranging from subcellular biomarker quantification to predictive patient stratification. The solutions support both routine diagnostics and the translation of novel biomarkers into real-world clinical applications.
For more information, visit www.mindpeak.ai or follow us on LinkedIn.
ABOUT MD HEALTH
MD Health is a forward-thinking, globally aware healthcare communications agency driven by a singular ethos: to ignite change. The agency is committed to transforming the healthcare landscape through impactful, purpose-driven communications that transcend traditional silos. MD Health partners with organisations across the healthcare sector to create powerful narratives that drive meaningful change. The agency's approach is rooted in a deep belief that effective communication and creativity combined with deep scientific expertise can shape the world as we know it, challenge conventions and improve lives.
MD Health is an MSDUK-certified ethnic minority-owned business and is proud to be setting new standards in the industry for inclusive leadership and meaningful, purpose-led work.
MD Health operates under the MD Comms Group umbrella.
Find out more at: www.mdcommsgroup.com
For further information, please contact:
Mita Dhullipala, CEO & Founder at MD Health
Email: mita.dhullipala@mdcommsgroup.com
Phone: +447989874986
